Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Jun 25, 2022 8:23pm
175 Views
Post# 34782636

RE:RE:RE:RE:RE:Bioasis Connections

RE:RE:RE:RE:RE:Bioasis ConnectionsI don't recommend getting rid of the current CEO. I don't like the secrets, some of which are not being well kept, and I don't think much of how the company is being presented. I think the corporate presentation is being used for disclosure manipulation and obfuscation.But I do support the initiatives.

Voting out DrDR would disrupt a number of those good initiatives. But she can do better. Her problem is hubris and her belief that she is being clever in her chess game with shareholders. She is not being clever! It's getting embarrassing.

She may be good strategically, but she is appalling tactically. Setting big goals and setting the board pieces are important, but these things don't matter much if you can't inspire the troops because you won't disclose accomplishments and possibilities of accomplishments.

However much she has accomplished, disclosed or secret, the fact remains that shareholders are upset, stressed, and the share price hit 16¢ this week.

Things can be done better. The message can be better.

jd
<< Previous
Bullboard Posts
Next >>